Can health insurance data predict drug success? massive study tests the theory
NCT ID NCT06914102
Summary
This study used health insurance records from over 58,000 people to see if real-world data can reliably answer the same questions as a formal clinical trial. It focused on patients with type 2 diabetes and a specific type of heart failure, comparing the outcomes of those taking the drug semaglutide versus another diabetes drug. The main goal was to understand when and how real-world data can be trusted for medical research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
Conditions
Explore the condition pages connected to this study.